Affinity Health Corp.

Nashville, Tennessee 37203

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Cardiovascular Diseases, Covid19, Hypertriglyceridemia, Post-acute COVID-19 Respiratory Disease

Studies at this site

• LYT-100 in Post-acute COVID-19 Respiratory Disease — Stopped early
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed